Amanda Matthews, Senior Director, Regulatory CMC for Combination Products & Medical Devices at Pfizer, provides an exclusive insight into the challenges of working between medical device and pharmaceutical companies, following the transition from development to commercial.
this year’s Drug-Device Combination Products conference, Amanda Matthews answers
the following questions:
Amanda Matthews will also participate in a round table and panel discussion at this year’s conference to discuss the impact of the EU MDR and how you can improve the collaboration to optimize processes. More information on the session can be found here.
Please note: That all fields marked with an asterisk (*) are required.